Medication Adherence among Pulmonary Tuberculosis Patients in Treatment Centers in a Southern Nigerian Local Government Area: Question Mark on Performance of DOTS Services https://doi.org/10.60787/NMJ-63-5-153
Main Article Content
Keywords
Pulmonary TB, medication adherence, DOTS, Nigeria
Abstract
Background: Directly observed treatment short-course (DOTS) offers free, accessible and effective treatments with high treatment success rate and retention. Despite this, evidence from Rivers State suggests a downward trend in tuberculosis (TB) cure rate and a high burden of drug resistance among pulmonary tuberculosis (PTB) patients. Medication adherence appears to play a key role in TB evolution.
Aim: to assess medication adherence and its determinants among pulmonary TB clients in DOTS centers.
Methodology: A total of 225 adult PTB clients from eight active DOTS centers in the Obio/Akpor Local Government Area of Rivers State were selected. A validated questionnaire, Morisky Medication adherence Scale-8 was used to collect the medication-taking behaviour of clients, dichotomised into adherent and non-adherent. Binary logistic regression was conducted to check the crude association between medication adherence and client/treatment factors. Variables with p<0.2 were selected and subjected to multivariate logistic regression with alpha set at p<0.05.
Results: Non-adherence to medication was 35.1%, with forgetfulness and stress with the medication plan as top reasons for non-adherence. Factors associated with non-adherence included persisting sputum production (aOR:2.951(1.027-8.482);p=0.045), past treatment history (aOR: 5.422(1.93-15.228);p=0.001) and smoking (aOR: 7.779(1.58-38.305);p=0.012).
Conclusion: Over one-third of PTB clients in DOTS centers in Obio/Akpor LGA were non-adherent to anti-TB medications. Factors associated with non-adherence included persisting sputum production, past treatment history and smoking. To attenuate these risk factors for non-adherence, training and retraining of DOTS center staff on counselling is a smart option that can be explored by the LGA, providers and managers of the DOTS programme.
References
2.Kastien-Hilka T, Abulfathi A, Rosenkranz B, Bennett B, Schwenkglenks M, Sinanovic E. Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis-a systematic review of global literature with focus on South Africa. Health Qual Life Outcomes. 2016;14:42.
3.Dim C, Dim N. Trends of tuberculosis prevalence and treatment outcome in an under-resourced setting: The case of Enugu state, South East Nigeria. Niger Med J.2013;54:392.
4.WHO. Adherence to Long-term Therapies: Evidence for Action. WHO. Geneva: WorldHealth Organization; 2015 . http://whqlibdoc.who.int/publications/2003/9 241545992.pdf
5.Oyefabi A, Adetiba E, Leeshak E, Adesigbin O. Tuberculosis and the determinants of treatment outcome in Zaria, North Western Nigeria -A nine-year (2007-2015) epidemiological review. J Med Trop. 2017;19:116.
6.Wor ld Health Organization. Global tuberculosis report 2018. Geneva. 2018. https://apps.who.int/iris/handle/10665/274453
7.Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. 1991. Bull World Health Organ.2001;79:71-5.
8.Fagundez G, Perez-Freixo H, Eyene J, Momo JC, Biyé L, Esono T, Ondó Mba Ayecab M,Benito A, Aparicio P, Herrador Z. Treatment Adherence of Tuberculosis Patients Attending Two Reference Units in Equatorial Guinea. PLoS One. 2016;11:e0161995.
9.Gube AA, Debalkie M, Seid K, Bisete K, Mengesha A, Zeynu A, et al. Assessment of Anti-TB Drug Nonadherence and Associated Factors among TB Patients Attending TB Clinics in Arba Minch Governmental Health Institutions, Southern Ethiopia. Tuberc ResTreat. 2018;2018:1-7.
10.Ubajaka CF, Azuike EC, Ugoji JO, Nwibo OE, Ejiofor OC, Modebe IA, et al. Adherence to Drug Medications amongst Tuberculosis Patients in a Tertiary Health Institution in South East Nigeria. Int J Clin Med. 2015; 6:399-406.
11.Anyaike C, Atoyebi OA, Musa OI, Bolarinwa OA, Durowade KA, Ogundiran A, et al. Adherence to combined antiretroviral therapy (cART) among people living with HIV/AIDS in a tertiary hospital in Ilorin, Nigeria. Pan AfrMed J. 2019;32.
12.Nwidu Ll, Blessing O, Abanee PSK. The Prevalence of Tuberculosis and Leprosy in Primary Health Care Levels in Rivers State, Nigeria. Biomed Pharmacol J. 2015;1:265-74.
13.Otokunefor K, Otokunefor TV, Omakwele G. Multi -drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria. Afr JLab Med. 2018;7.14.Kasiulevicius V, Šapoka V, FilipaviciuteR. Sample size calculation in epidemiological studies. Gerontologija. 2006;7:225-31.
15.Gabriel-Job N, Ni P,Nathaniel TI. Prevalence o f Pulmonary Tuberculosis among Presumptive Cases in Rivers State, Nigeria. IntJ Trop Dis Heal. 2019;1:1-9.
16.De las Cuevas C, Peñate W. Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting. Int J Clin HealPsychol. 2015;15:121-9.
17.Okello S, Nasasira B, Muiru ANW, Muyingo A. Validity and reliability of a self-reportedmeasure of antihypertensive medication adherence in Uganda. Reboldi G, editor. PLoSOne. 2016;11:e0158499.
18.Sariem C, Gyang SS, Tayo F, Auta A. Factors Influencing Tuberculosis Medication Adherence in a Tertiary Health in Nigeria. WestAfrican J Pharm. 2013;24:66-75.
19.Xu M, Markström U, Lyu J, Xu L. Detection of Low Adherence in Rural Tuberculosis Patients in China: Application of Morisky Medication Adherence Scale. Int J Environ Res PublicHealth. 2017;14:248.
20.Tobin-West C, Isodje A. Quality and rural-urban comparison of tuberculosis care in Rivers State, Nigeria. Pan Afr Med J. 2016;24.
21.Salma S, Siddiqua AA, Keerthana RSSL, Suryadevara M, Prabhakar DV, Pingili R. Assessment of medication adherence, quality of life and risk factors among patients with tuberculosis in a South Indian tertiary care hospital: a cross-sectional study. Int J SciReports. 2019;5:213.
22.Holtzman CW, Brady KA, Yehia BR. Retention in Care and Medication Adherence: CurrentChallenges to Antiretroviral Therapy Success. Drugs. 2015;75:445-54.
23.Negesa L. Adherence to Antiretroviral Therapy and Factors affecting among People Living with HIV/AIDS and Taking Antiretroviral Therapy, Dire Dawa Town, Eastern Ethiopia. JInfect Dis Treat. 2017;03.
24.Berhan A, Berhan Y, Yizengaw D. A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection? Ethiop J Health Sci.2013;23:271-82.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.
Lucky Obukowho Onotai, Department of Ear Nose and Throat Surgery, University of Port HarcourtTeaching Hospital, Rivers State, Nigeria
Department of Ear Nose and Throat Surgery / Consultant